12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/17/2024
8:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
08/19/2024
4:14 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2024
3:40 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/03/2024
7:39 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/03/2024
7:44 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
8:01 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:05 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/24/2024
3:06 PM | Checkpoint Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/17/2024
4:13 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
05/16/2024
6:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:34 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:35 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:31 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
5:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
5:03 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/29/2024
4:03 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
5:23 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
5:24 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
03/22/2024
4:19 PM | Checkpoint Therapeutics (Filer)
| Form PRE 14A | |
Did You See Trump’s Bombshell Exec. Order 001? (Ad) Biden broke it... Now Trump is going to fix it.
Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. |
03/22/2024
4:13 PM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:52 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:31 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/02/2024
7:15 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:05 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/02/2024
7:10 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:15 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:01 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
